CSRT vs. EKF, ERGO, SLN, AMS, AMYT, OXB, PRTC, MXCT, APH, and HZD
Should you be buying Consort Medical plc (CSRT.L) stock or one of its competitors? The main competitors of Consort Medical plc (CSRT.L) include EKF Diagnostics (EKF), Ergomed (ERGO), Silence Therapeutics (SLN), Advanced Medical Solutions Group (AMS), Amryt Pharma (AMYT), Oxford Biomedica (OXB), PureTech Health (PRTC), MaxCyte (MXCT), Alliance Pharma (APH), and Horizon Discovery Group plc (HZD.L) (HZD). These companies are all part of the "medical" sector.
Consort Medical plc (CSRT.L) vs.
Consort Medical plc (CSRT.L) (LON:CSRT) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, community ranking, earnings, risk, media sentiment, analyst recommendations and institutional ownership.
Consort Medical plc (CSRT.L) received 23 more outperform votes than EKF Diagnostics when rated by MarketBeat users. However, 76.76% of users gave EKF Diagnostics an outperform vote while only 75.11% of users gave Consort Medical plc (CSRT.L) an outperform vote.
In the previous week, EKF Diagnostics had 2 more articles in the media than Consort Medical plc (CSRT.L). MarketBeat recorded 2 mentions for EKF Diagnostics and 0 mentions for Consort Medical plc (CSRT.L). EKF Diagnostics' average media sentiment score of 0.49 beat Consort Medical plc (CSRT.L)'s score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media.
62.0% of EKF Diagnostics shares are held by institutional investors. 5.5% of EKF Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Consort Medical plc (CSRT.L) has higher revenue and earnings than EKF Diagnostics. EKF Diagnostics is trading at a lower price-to-earnings ratio than Consort Medical plc (CSRT.L), indicating that it is currently the more affordable of the two stocks.
Consort Medical plc (CSRT.L) has a net margin of 0.00% compared to EKF Diagnostics' net margin of -15.16%. Consort Medical plc (CSRT.L)'s return on equity of 0.00% beat EKF Diagnostics' return on equity.
Consort Medical plc (CSRT.L) pays an annual dividend of GBX 0.28 per share and has a dividend yield of 0.0%. EKF Diagnostics pays an annual dividend of GBX 1 per share and has a dividend yield of 3.3%. Consort Medical plc (CSRT.L) pays out 3.5% of its earnings in the form of a dividend. EKF Diagnostics pays out -5,000.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. EKF Diagnostics is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
EKF Diagnostics beats Consort Medical plc (CSRT.L) on 9 of the 15 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CSRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Consort Medical plc (CSRT.L) Competitors List
Related Companies and Tools
